| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Unknown |
| Molecule Category: | UNKNOWN |
| UNII: | 6RQ92PNH8Z |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| HYDROLYTIC ENZYME | RNA hydrolytic enzyme |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Sjogren's Syndrome | 2 | D012859 | ClinicalTrials |
| Lupus Erythematosus, Systemic | 2 | D008180 | ClinicalTrials |
| Post-Acute COVID-19 Syndrome | 2 | D000094024 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4297821 |
| FDA SRS | 6RQ92PNH8Z |
| Guide to Pharmacology | 10412 |
CONTENTS